Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
🔒 NordVPN Premium – 3 Months
hrdilshan
Updated:
Thursday at 8:29 PM
🚀 Microsoft Office 365 Pro Plus – Lifetime Access! 🚀
hrdilshan
Updated:
Thursday at 8:28 PM
Linkedin Premium Business / Careere /Sales Navigator - 1/2/3/6/9/12 Months - Reddem Link
hrdilshan
Updated:
Thursday at 8:27 PM
Colombo
YEYE 3 in 1 Instant Coffee Mix 50 Sachet
Romeshka
Updated:
Wednesday at 12:16 AM
Colombo
Red Hat Certified System Administrator (RHCSA) - RHEL 10
Sanjeewani95
Updated:
Jul 3, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
A Potent Antibody that Neutralizes All Covid variants.
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 28150660" data-attributes="member: 562115"><p><u><strong>An Antibody from Single Human VH-rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion.</strong></u></p><p></p><p>A research team from the US has announced a mouse model used to generate a VH1-2 heavy chain (HC)- and Vκ1-33 light chain (LC)-based recombinant antibody that broadly neutralized all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, <strong>including the newly emergent Omicron sub-variant BA.5</strong>.</p><p></p><p>Human monoclonal antibodies derived from B cells of patients infected from the early SARS-CoV-2 variants and from vaccinated individuals are rapidly losing their efficacy with the emergence of new Omicron sub-variants. The SARS-CoV-2 spike protein binds to the angiotensin-converting enzyme 2 (ACE2) receptor on the host cell surface. The spike protein is made of non-covalently linked subunits S1, which contains the receptor binding domain (RBD), and S2, which anchors the spike protein and forms the fusion pore after spike protein cleavage.</p><p></p><p>Humanized mice carrying immunoglobulin genes have earlier yielded monoclonal antibodies that successfully neutralized <strong>some</strong> of the SARS-CoV-2 variants but have not been developed to yield antibodies that neutralize the Omicron sub-variants.</p><p></p><p>The present study reports the generation of a broadly neutralizing monoclonal antibody developed using a humanized mouse model carrying single VH1-2 heavy chain (HC) and Vκ1-33 light chain (LC) segments. The SP1-77 antibody differs from previous monoclonal antibodies in the mechanism of SARS-CoV-2 inhibition, as well as the SARS-CoV-2 RBD epitope of binding. The researchers have established a successful prototype for using humanized mouse models carrying VH and Vκ segments to generate a diversity of antibodies and demonstrated the potential of using mouse models to develop humanized antibodies against various pathogens.</p><p></p><p>PS: Pls see another update below on another set of antibodies discovered by an Israeli team.</p></blockquote><p></p>
[QUOTE="imhotep, post: 28150660, member: 562115"] [U][B]An Antibody from Single Human VH-rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion.[/B][/U] A research team from the US has announced a mouse model used to generate a VH1-2 heavy chain (HC)- and Vκ1-33 light chain (LC)-based recombinant antibody that broadly neutralized all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, [B]including the newly emergent Omicron sub-variant BA.5[/B]. Human monoclonal antibodies derived from B cells of patients infected from the early SARS-CoV-2 variants and from vaccinated individuals are rapidly losing their efficacy with the emergence of new Omicron sub-variants. The SARS-CoV-2 spike protein binds to the angiotensin-converting enzyme 2 (ACE2) receptor on the host cell surface. The spike protein is made of non-covalently linked subunits S1, which contains the receptor binding domain (RBD), and S2, which anchors the spike protein and forms the fusion pore after spike protein cleavage. Humanized mice carrying immunoglobulin genes have earlier yielded monoclonal antibodies that successfully neutralized [B]some[/B] of the SARS-CoV-2 variants but have not been developed to yield antibodies that neutralize the Omicron sub-variants. The present study reports the generation of a broadly neutralizing monoclonal antibody developed using a humanized mouse model carrying single VH1-2 heavy chain (HC) and Vκ1-33 light chain (LC) segments. The SP1-77 antibody differs from previous monoclonal antibodies in the mechanism of SARS-CoV-2 inhibition, as well as the SARS-CoV-2 RBD epitope of binding. The researchers have established a successful prototype for using humanized mouse models carrying VH and Vκ segments to generate a diversity of antibodies and demonstrated the potential of using mouse models to develop humanized antibodies against various pathogens. PS: Pls see another update below on another set of antibodies discovered by an Israeli team. [/QUOTE]
Insert quotes…
Verification
Asuwa dahayen wadi kalama keeyada?
Post reply
Top
Bottom